Prefrontal dopaminergic receptor abnormalities and cognitive functions in Parkinson's disease

被引：0
|
作者：
Ko, J. H.
Antonelli, F.
Monchi, O.
Ray, N.
Rusjan, P. M.
Houle, S.
Christopher, L.
Strafella, A. P.
机构：
来源：
MOVEMENT DISORDERS | 2011年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S153 / S154
页数：2
相关论文
共 50 条
  • [31] Cognitive functions in Parkinson's disease: Relation to disease severity and hallucination
    Wakamori, Takaaki
    Agari, Takashi
    Yasuhara, Takao
    Kameda, Masahiro
    Kondo, Akihiko
    Shinko, Aiko
    Sasada, Susumu
    Sasaki, Tatsuya
    Furuta, Tomohisa
    Date, Isao
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (04) : 415 - 420
  • [32] Metabolic Abnormalities Associated with Progressive Cognitive Dysfunction in Parkinson's Disease
    Poston, Kathleen L.
    Mattis, Paul
    Tang, Chengke
    Bussa, Matthew
    Eidelberg, David
    NEUROLOGY, 2009, 72 (11) : A114 - A115
  • [33] Dopaminergic Medication Improves Cognitive Control Under Low Cognitive Demand in Parkinson's Disease
    Williams, Isobel A.
    Obeso, Ignacio
    Jahanshahi, Marjan
    NEUROPSYCHOLOGY, 2020, 34 (05) : 551 - 559
  • [34] Cognitive Executive Impairment and Dopaminergic Deficits in De Novo Parkinson's Disease
    Siepel, Francoise J.
    Bronnick, Kolbjorn S.
    Booij, Jan
    Ravina, Bernard M.
    Lebedev, Alexander V.
    Pereira, Joana B.
    Gruner, Renate
    Aarsland, Dag
    MOVEMENT DISORDERS, 2014, 29 (14) : 1802 - 1808
  • [35] Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease
    Fera, Francesco
    Nicoletti, Giuseppe
    Cerasa, Antonio
    Romeo, Nelide
    Gallo, Olivier
    Gioia, Maria C.
    Arabia, Gennarina
    Pugliese, Pierfrancesco
    Zappia, Mario
    Quattrone, Aldo
    BRAIN RESEARCH BULLETIN, 2007, 74 (1-3) : 75 - 83
  • [36] A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease
    Relja, M.
    Klepac, N.
    MOVEMENT DISORDERS, 2006, 21 : S468 - S468
  • [37] A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease
    Relja, Maja
    Klepac, Natasa
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 251 - 254
  • [38] Physical activity and cognitive functions in individuals with Parkinson's disease
    Loureiro, A. P. C.
    Israel, V. L.
    Yamaguchi, B.
    MOVEMENT DISORDERS, 2021, 36 : S3 - S3
  • [39] A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease
    Relja, Maja
    Klepac, Natasa
    Miletic, Vladimir
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 120 - 120
  • [40] The influence of stereotactic surgeries on cognitive functions in Parkinson's disease
    Ackermann, D
    Gorzelanczyk, EJ
    Harat, M
    Laskowska, I
    Litwinowicz, A
    Olzak, M
    Szolna, A
    12TH EUROPEAN CONGRESS OF NEUROSURGERY (EANS), PROCEEDINGS, 2003, : 985 - 989
12345